Skip to contentC
Cryo Cell International Inc
C
CCELCryo Cell International Inc Q1 2022 · 10-Q
Revenue$7.26M$7.26M+5.8% vs Q1 2021 Net Income$832.05K$832.05K+20.0% vs Q1 2021 EPS Diluted$0.10$0.10+25.0% vs Q1 2021 Operating Income$1,470,422+19.0% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cryo Cell International Inc · CIK 862692 · Engraved from SEC EDGAR
Free Cash Flowderived$859,122−67.6% Margins · derivedOperating margin20.3%+2.3 pt vs Q1 2021
Net margin11.5%+1.4 pt vs Q1 2021
ended Feb 28, 2022 · filed Apr 13, 2022 · 44 d after period end